145 related articles for article (PubMed ID: 11385298)
1. Expression of human Fas ligand on mouse beta islet cells does not induce insulitis but is insufficient to confer immune privilege for islet grafts.
Hsu PN; Lin HH; Tu CF; Chen NJ; Wu KM; Tsai HF; Hsieh SL
J Biomed Sci; 2001; 8(3):262-9. PubMed ID: 11385298
[TBL] [Abstract][Full Text] [Related]
2. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
Suarez-Pinzon W; Sorensen O; Bleackley RC; Elliott JF; Rajotte RV; Rabinovitch A
Diabetes; 1999 Jan; 48(1):21-8. PubMed ID: 9892218
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
[TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.
Allison J; Georgiou HM; Strasser A; Vaux DL
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3943-7. PubMed ID: 9108084
[TBL] [Abstract][Full Text] [Related]
5. The effect of FasL gene transfer to islet cells on pancreatic islet allografts.
Cai SR; He YL; Huang MJ; Peng JS; Wang JP; Zhan WH
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):308-12. PubMed ID: 14599991
[TBL] [Abstract][Full Text] [Related]
6. Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance.
Wang XY; Sun J; Wang C; France M; Sheil AG
Transplantation; 2001 Jan; 71(1):102-11. PubMed ID: 11211174
[TBL] [Abstract][Full Text] [Related]
7. [Role of Fas, FasL in NOD insulitis].
Cao JY; Wang H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):486-90. PubMed ID: 12905770
[TBL] [Abstract][Full Text] [Related]
8. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
Redd S; Ginn S; Ross JM
Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice.
Yolcu ES; Zhao H; Bandura-Morgan L; Lacelle C; Woodward KB; Askenasy N; Shirwan H
J Immunol; 2011 Dec; 187(11):5901-9. PubMed ID: 22068235
[TBL] [Abstract][Full Text] [Related]
10. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.
Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M
Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172
[TBL] [Abstract][Full Text] [Related]
11. Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts.
Tourneur L; Malassagne B; Batteux F; Fabre M; Mistou S; Lallemand E; Lores P; Chiocchia G
J Immunol; 2001 Aug; 167(3):1338-46. PubMed ID: 11466351
[TBL] [Abstract][Full Text] [Related]
12. The role of Fas ligand in beta cell destruction in autoimmune diabetes of NOD mice.
Petrovsky N; Silva D; Socha L; Slattery R; Charlton B
Ann N Y Acad Sci; 2002 Apr; 958():204-8. PubMed ID: 12021107
[TBL] [Abstract][Full Text] [Related]
13. In vivo controlling of cellular response to pig islet xenografts by adenovirus-mediated expression of either membrane-bound human FasL or human decoy Fas.
Kawamoto K; Tanemura M; Deguchi T; Machida T; Nishida T; Sawa Y; Doki Y; Mori M; Ito T
Transplant Proc; 2009; 41(1):331-3. PubMed ID: 19249549
[TBL] [Abstract][Full Text] [Related]
14. [Co-transplantation of islet and allogeneic testicular cell induced immune privilege].
Lan P; Yan L; Zhan W; Xiao L
Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):208-10. PubMed ID: 11829820
[TBL] [Abstract][Full Text] [Related]
15. Accelerated rejection of Fas ligand-expressing heart grafts.
Takeuchi T; Ueki T; Nishimatsu H; Kajiwara T; Ishida T; Jishage K; Ueda O; Suzuki H; Li B; Moriyama N; Kitamura T
J Immunol; 1999 Jan; 162(1):518-22. PubMed ID: 9886428
[TBL] [Abstract][Full Text] [Related]
16. Expression of Fas but not Fas ligand on fetal pig beta cells.
Bai L; Maedler K; Donath M; Tuch BE
Xenotransplantation; 2004 Sep; 11(5):426-35. PubMed ID: 15303979
[TBL] [Abstract][Full Text] [Related]
17. The effect of FasL expression on pancreatic islet allografts.
Zhan W; Cai S; Wang J; He Y; Zheng Z; Peng J
Chin Med J (Engl); 2002 Jul; 115(7):1006-9. PubMed ID: 12150731
[TBL] [Abstract][Full Text] [Related]
18. [Effects of Fas ligand expression on pancreatic islet allografts].
Cai S; Zhan W; He Y
Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):634-7. PubMed ID: 11758207
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege.
Woodward KB; Zhao H; Shrestha P; Batra L; Tan M; Grimany-Nuno O; Bandura-Morgan L; Askenasy N; Shirwan H; Yolcu ES
Am J Transplant; 2020 May; 20(5):1285-1295. PubMed ID: 31850658
[TBL] [Abstract][Full Text] [Related]
20. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction.
Kang SM; Schneider DB; Lin Z; Hanahan D; Dichek DA; Stock PG; Baekkeskov S
Nat Med; 1997 Jul; 3(7):738-43. PubMed ID: 9212099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
